Allergen immunotherapy for allergic asthma.
Allergol Select
; 8: 6-11, 2024.
Article
in En
| MEDLINE
| ID: mdl-38249819
ABSTRACT
Remission is the goal of modern asthma treatment. Allergen immunotherapy (AIT) is an essential component in the armamentarium of personalized asthma therapy. Subcutaneous AIT (SCIT) or sublingual AIT (SLIT) offer the possibility to prevent asthma in patients with allergic rhinitis (reduction of the risk of developing asthma) and the possibility to achieve remission in patients with allergic asthma. Accordingly, AIT should always be considered in patients with asthma and a documented, clinically relevant allergy. However, precise phenotyping of the patient is an essential prerequisite for a success of AIT in asthma.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Allergol Select
Year:
2024
Document type:
Article